T1	Pharmacodynamic_phenotype	50 71	hematologic responses
T2	Limited_variation	87 104	V617F ( molecular
T3	Disease	136 161	polycythemia vera treated
T4	Chemical	174 229	interferon ( rIFNa-2b : 28 , Peg-rIFNa-2a : 18 ) or non
T5	Chemical	230 259	interferon drugs ( n = 27 ) ,
T6	Chemical	282 324	urea ( n = 8 ) , imatinib ( n = 12 ) , das
T7	Chemical	324 367	atinib ( n = 5 ) , busulfan ( n = 1 ) , and
T8	Chemical	368 402	radioactive phosphorus ( n = 1 ) .
R1	isAssociatedWith	Arg1:T1	Arg2:T2
R2	isAssociatedWith	Arg1:T1	Arg2:T3
R3	isAssociatedWith	Arg1:T1	Arg2:T4
R4	isAssociatedWith	Arg1:T1	Arg2:T5
R5	isAssociatedWith	Arg1:T1	Arg2:T6
R6	isAssociatedWith	Arg1:T1	Arg2:T7
R7	isAssociatedWith	Arg1:T1	Arg2:T8
R8	isAssociatedWith	Arg1:T2	Arg2:T1
R9	isAssociatedWith	Arg1:T2	Arg2:T3
R10	isAssociatedWith	Arg1:T2	Arg2:T4
R11	isAssociatedWith	Arg1:T2	Arg2:T5
R12	isAssociatedWith	Arg1:T2	Arg2:T6
R13	isAssociatedWith	Arg1:T2	Arg2:T7
R14	isAssociatedWith	Arg1:T2	Arg2:T8
R15	treats	Arg1:T4	Arg2:T1
R16	treats	Arg1:T4	Arg2:T2
R17	treats	Arg1:T4	Arg2:T3
R18	treats	Arg1:T5	Arg2:T3
R19	influences	Arg1:T5	Arg2:T4
R20	treats	Arg1:T6	Arg2:T3
R21	influences	Arg1:T6	Arg2:T4
R22	influences	Arg1:T6	Arg2:T5
R23	treats	Arg1:T7	Arg2:T1
R24	treats	Arg1:T7	Arg2:T2
R25	treats	Arg1:T7	Arg2:T3
R26	influences	Arg1:T7	Arg2:T4
R27	influences	Arg1:T7	Arg2:T5
R28	isAssociatedWith	Arg1:T8	Arg2:T1
R29	treats	Arg1:T8	Arg2:T3
R30	influences	Arg1:T8	Arg2:T4
R31	influences	Arg1:T8	Arg2:T5
R32	influences	Arg1:T8	Arg2:T6
